Data / Form D filings / Amicrobe, Inc.
Amicrobe, Inc.: Form D filings
Amicrobe, Inc., a biotechnology company in Carlsbad, CA, filed 3 Form D notices with the SEC between 2011 and 2024. The latest, on April 25, 2024, reports $16.7 million sold of a $24.6 million offering to 32 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3142 TIGER RUN COURT, SUITE 101, Carlsbad, CA, 92010
- Phone
- (888) 490-1180
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1513330
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 25, 2024 | New notice | $24,561,600 | $16,740,243 | $7,821,357 | 32 | May 28, 2020 | sec.gov |
| Apr 25, 2024 | New notice | $5,000,003 | $5,000,003 | 51 | Sep 20, 2013 | sec.gov | |
| Feb 22, 2011 | New notice | $4,002,000 | $999,987 | $3,002,013 | 5 | Feb 7, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Albert Carnesale | Director | |
| Michael Bevilacqua | Executive Officer, Director | |
| Michael Flesch | Executive Officer, Director | |
| Martin Burns | Director | |
| Daniel Huang | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Apr 22, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Amicrobe, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.